JNJ · Johnson & Johnson
$256.35
+0.53 (+0.21%)
At close · Jul 31
Market Cap
$616.50B
Shares
2.41B
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| John Morikis | Board of Directors | Appointed | 2025-09-09 |
| Daniel Pinto | Board of Directors | Appointed | 2025-06-10 |
| D. Adamczyk | Board of Directors | Retired | 2025-04-30 |
Key facts
CIK
200406
CUSIP
478160104
13F (30d)
2292 filings
2245 filers
Visit website
Investor relations